PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer.

Autor: Lænkholm, Anne-Vibeke, Jensen, Maj-Britt, Eriksen, Jens Ole, Rasmussen, Birgitte Bruun, Knoop, Ann S., Buckingham, Wesley, Ferree, Sean, Schaper, Carl, Nielsen, Torsten O., Haffner, Taryn, Kibøl, Torben, Møller Talman, Maj-Lis, Bak Jylling, Anne Marie, Tabor, Tomasz Piotr, Ejlertsen, Bent, Lænkholm, Anne-Vibeke, Kibøl, Torben, Møller Talman, Maj-Lis
Zdroj: Journal of Clinical Oncology; 3/10/2018, Vol. 36 Issue 8, p735-740, 9p
Databáze: Supplemental Index